Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis
Go back to Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 14.37 +0.13 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $18.64 | |||
| Open | $14.47 | 52 Week Low | $12.59 | |||
| Day High | $14.60 | P/E | N/A | |||
| Day Low | $14.34 | EPS | $0.00 | |||
| Volume | 57,467 | |||||
| (AMEX: KYKOY) | Delayed: 19.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.80 | 52 Week High | $ | |||
| Open | $19.80 | 52 Week Low | $ | |||
| Day High | $19.80 | P/E | N/A | |||
| Day Low | $19.80 | EPS | $ | |||
| Volume | 76 | |||||
